Proteintech Launches “Able” AI – A First-of-Its-Kind Tool to Accelerate Scientific Discovery
Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on ptglab.com.
Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all relevant information and associated scientific knowledge. In addition, it offers detailed guidance on product specific experimental procedures, significantly reducing the time spent on planning and product selection.
This release follows Proteintech’s successful introduction of 3D Epitope Mapping earlier this year, which advanced researchers’ ability to visualize antibody binding sites through experimental and AI-powered modelling. This capability reduces guesswork and trial-and-error, enabling scientists to better design experiments and develop products with greater precision.
“Able represents the next phase in our mission to empower scientists,” said Dr. Jason Li, CEO of Proteintech. “Building on the success of our 3D Epitope Mapping platform, Able delivers tailored product recommendations and experimental design support, allowing researchers to focus more on their cutting-edge discoveries. Proteintech strives to push boundaries in the reagent world for better science and better service for every customer.”
Able is available immediately and free to use at ptglab.com or directly at www.ptglab.com/Able.
About Proteintech
Proteintech Group Inc., founded in 2001, is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering two-thirds of the human proteome. Proteintech offers antibodies, proteins and immunoassays across research areas with over 300,000 products cited. In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade. Proteintech sites are ISO13485 and ISO9001 accredited.
For more information, visit ptglab.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250902324418/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dalton Maag Challenges OEM Font Status Quo with MetricsMatch3.9.2025 07:00:00 CEST | Press release
Dalton Maag, the independent typeface design studio known for its high-performance library fonts and custom typefaces for global brands, today launched MetricsMatch – a font solution for Original Equipment Manufacturers (OEMs). The new range provides a cost-effective, high-quality alternative to the industry-standard font sets embedded in consumer electronics, printers, and other devices. For years, OEMs have expressed frustration with current licensing models, citing high costs, limited flexibility, and vendor lock-in. MetricsMatch directly addresses these challenges with open pricing, fair licensing, and customization options, introducing competition to the market. At the heart of MetricsMatch is metrics compatibility, which enables the seamless substitution of fonts, reducing integration effort and accelerating time-to-market for established players and new entrants. “We've heard the frustrations of manufacturers who feel trapped by the current licensing landscape,” said David Marsh
YES Receives Orders for Multiple VertaCure™ G3 Systems From Asia’s Leading Foundry3.9.2025 02:07:00 CEST | Press release
Yield Engineering Systems (YES), a leading provider of process equipment for AI and HPC semiconductor applications, today announced orders of multiple VertaCure™ G3 curing systems from one of Asia’s top foundries. These systems will support advanced packaging processes for AI and HPC solutions, delivering critical low-temperature curing, annealing, and degassing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902880940/en/ VertaCure XP G3 The VertaCure™ G3 is a fully automated vacuum curing and degassing system engineered to ensure uniform temperature distribution and precise control of heating and cooling rates. This results in complete solvent removal, improved film properties, elimination of outgassing after cure, and outstanding particle performance. YES products have consistently demonstrated superior quality in curing, coating, and annealing across both R&D and high-volume manufacturing environments. “The VertaCure™
Lantern Appoints Jeff Williams as Chief Product Officer, Marking Expansion into the US2.9.2025 20:03:00 CEST | Press release
Lantern, the data intelligence platform for private markets, today announced the appointment of Jeff Williams as its first Chief Product Officer (CPO). Based in the United States, Jeff’s appointment marks a major milestone as Lantern establishes its presence in North America, to support its rapidly growing global client base. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902271705/en/ Jeff Williams, Lantern Chief Product Officer Jeff brings more over 15 years’ experience at the intersection of private markets and technology. Most recently, he served as Chief Strategy Officer at Altvia, where he played a central role in shaping product strategy, guiding product launches, and driving growth. Edward Moore, Founder and CEO of Lantern, commented: “Jeff has a rare blend of product expertise and deep knowledge of private markets. He’s led product strategy through periods of intense growth and complexity, and his experience will
Coherent Solutions secures strategic investment from IceLake Capital to fuel global growth2.9.2025 18:48:00 CEST | Press release
Coherent Solutions, a global digital solutions engineering firm, has secured a strategic investment from IceLake, a leading private equity investor specializing in partnering with high-growth business services organizations. The partnership will accelerate Coherent Solutions’ global expansion and solution offerings, advancing its mission to deliver measurable digital value creation for clients worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902336956/en/ Coherent Solutions has secured a strategic investment from IceLake, advancing its mission to deliver measurable digital value creation for clients worldwide. This year marks Coherent Solutions’ 30th anniversary. Since its founding in 1995, the company has partnered with some of the world’s largest brands and most ambitious growth companies to design, develop, and launch sophisticated digital platforms and solutions. “The partnership with IceLake is a strong vote
MSP Sports Capital Confirms Sale of its Holdings in McLaren Racing to McLaren Group Limited2.9.2025 17:02:00 CEST | Press release
As announced earlier today, McLaren Group Limited has completed the purchase of MSP Sports Capital’s equity interest in McLaren Racing, including its Formula 1 Team. The transaction will enable Bahrain Mumtalakat Holding Company and CYVN Holding, an advanced mobility operator and investment vehicle based in Abu Dhabi, to increase their share and assume full ownership of the iconic British motor racing business. Mumtalakat will continue as majority shareholder with CYVN Holdings owning a non-controlling stake. MSP’s investment came at a pivotal moment in the business, providing vital capital that contributed to the company’s efforts in stabilizing business operations during the COVID-19 pandemic, funding infrastructure upgrades, and retaining and recruiting world-class talent. Over the last five years, with the support received from its shareholders, McLaren has returned to the front of the Formula 1 grid, rebuilt its competitiveness across multiple racing series, and enhanced its long
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom